Atea Pharmaceuticals (AVIR) Cash flow

245 Followers

Atea Pharmaceuticals Cash Flow

AVIR's free cash flow for Q4 2025 was $-28.22M. For the 2025 fiscal year, AVIR's free cash flow was decreased by $3.47M and operating cash flow was $-28.22M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -132.03M	$ -135.50M	$ -85.39M	$ -120.98M	$ -87.00M
Investing Cash Flow	$ 188.79M	$ 56.10M	$ 40.30M	$ -455.41M	$ -4.00K
Financing Cash Flow	$ -25.75M	$ 267.00K	$ 257.00K	$ 370.00K	$ 1.47M
End Cash Position	$ 95.71M	$ 64.70M	$ 143.82M	$ 188.66M	$ 764.68M
Free Cash Flow	$ -132.03M	$ -135.50M	$ -85.39M	$ -122.92M	$ -87.01M

Currency in USD